Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abalos E, Duley L, Steyn DW, Henderson-Smart BJ (2001) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy (Cochrane review). Cochrane Database Syst Rev 2001: CD 00252
ACOG Comittee Opinion 211 (1998) Anticoagulation with low molecular weight heparin during pregnancy. Washington DC
ACOG (2001) Chronic hypertension in pregnancy. Pract Bull 29
ACOG (2002) Diagnosis and management of preeclampsia and eclampsia. Pract Bull 33
Ahmad S, Ahmed A (2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95: 884–891
Ai RA, Baykal C, Karacay O et al. (2004) Random urine protein-creatinine ratio to predict proteinuria in new-onset mild hypertension in late pregnancy. Obstet Gynecol 104(2): 367–371
Ascarelli MH, Johnson V, McCreary H et al. (2005) Postpartum preeclampsia management with Furosemid: a randomized clinical trial. Obstet Gynecol 105: 29–33
Atallah AN, Hofmeyr GJ, Dulay L (2000) Calcium supplementation during prgnancy for preventing hypertensive disorders and related problems (Cochrane Review) In: The Cochrane Library, Issue 1. Oxford Updated Software 2000
Atkinson MW, Belfort MA, Saade GR, Moise KJ (1994) The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol 83: 967–970
Barron WM, Heckerling P, Hibbard JU, Fisher S (1999) Reducing unnecces-sary coagulation testing in hypertensive disorders of pregnancy. Obstet Gynecol 94: 364–370
Barton JR, Sibai BM (1996) Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets count). Am J Obstet Gynecol 174: 1820–1825
Barton JR, Sibai BM, Mabie WC, Shanklin DR (1990) Recurrent acute fatty liver of pregnancy. Am J Obstet Gynecol 163: 534–538
Barton JR, O’Brian JM, Bergauer NK et al. (2001) Mild gestational hypertension remote from term: Progession and outcome. Am J Obstet Gynecol 184: 979–983
Baschat AA, Gembruch U, Harman CR (2001) The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 18: 581–577
Beazley D, Ahokas R, Livingston J et al. (2005) Vitamin C and E supplementation in women at risk of preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 192: 520–521
Belfort MA, Moise KJ (1992) Effect of magnesiumsulfate on maternal brain blood flow in preeclampsia: a randomized placebo-controlled study. Am J Obstet Gynecol 167: 661–666
Belizan JM, Villar J, Gonzalez L, Campodonica L, Bergel E (1991) Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 325: 1399–1405
Ben-Ami M, Giladi Y, Shalev E (1994) The combination of magnesium sulfate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 101: 262–263
Bosio PM, McKenna PJ, Conroy R, O’Herlihy C (1999). Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 94: 978–984
Brauch DW, Khamashta MA (2003) Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 101: 1333–1344
Broekenhuizen FF, Elejalde R, Hamilton RR (1983) Early onset preeclampsia, triploidy and fetal hydrops. J Reprod Med 28: 223–226
Brown MA (1990) Non-pharmacological management of pregnancy-induced hypertension. J Hypertens 8: 295–301
Bucher HC, Guyatt GH, Cook RJ, Hatala R, Cook DJ, Lang JD, Hunt D (1996) Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized trials. J Am Med Assoc 275: 1113–1117
Butters L, Kennedy S, Rubin PC (1990) Atenolol in essential hypertension during pregnancy. Br Med J 301: 587
Castro MA, Fassett MJ, Reynolds TB, Shaw KJ, Goodwin TM (1999) Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 181: 389–395
Chames MC, Haddad B, Barton RJ et al. (2003) Subsequent pregnancy outcome in women with a history of Hellp syndrome at ≤28 weeks of gestation. Am J Obstet Gynecol 188: 1504–1507
Chang EY, Menard MK, Vermillion ST et al. (2004) The association between hyaline membrane disease and preeclampsia. Am J Obstet Gynecol 191: 1414–1417
Chapell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bensley SJ, Shenaen AH, Steer PHJ, Poston L (1999) Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomised trial. Lancet 354: 810–816
Chesley LC, Annillo JE, Cosgrove RA (1976) The remote prognosis of preeclamptic women: sixth period report. Am J Obstet Gynecol 124: 446–459
Conde-Agudelo A, Villar J, Lindheimer M (2004) World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 104: 1367–1391
Coppage KH, Polzin WJ (2002) Severe preeclampsia and delivery outcomes: Is immediate Cesarean delivery beneficial? Am J Obstet Gynecol 186: 921–923
Dashe JS, Ranin SM, Cinningham FG (1998) The long term consequences of thrombotic microangiopathy in pregnancy. Obstet Gynecol 91: 662–668
Davison JW (1991) Dialysis, transplantation and pregnancy. Am J Kidney Dis 17: 127–132
Dekker G, Sibai BM (1993) Low dose aspirin in the prevention of preeclampsia and fetal growth retardation: rational mechanisms and clinical trials. Am J Obstet Gynecol 168: 214–227
Dekker G, Sibai BM (2001) Primary, secondary and tertiary prevention of preeclampsia. Lancet 357: 207–215
Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C, van Geijn HP (1995) Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 173: 1042–1048
Derks JB, Mulder EJH, Visser GHA (1995) The effects of maternal bethametasone administration on the fetus. Br J Obstet Gynaecol 102: 40–46
Douglas KA, Redman CWG (1994) Eclampsia in the United Kingdom. BMJ 309: 1395–1400
Duckitt K, Harrington B (2005) Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. Br Med J 330: 565
Duley L, Henderson-Smart D, Knight M, King J (2004) Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 1: CD 004659
Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia ? Evidence from the Collaborative Eclampsia Trial. Lancet 345: 1455–1463
Empson M, Lassere M, Craig JC, Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99: 135–144
Fenakel K, Fenakel G, Appelman Z et al. (1991) Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 77: 331–337
Ferrer RL, Sibai BM, Muhrow CD et al. (2000) Management of mild chronic hypertension during pregancy: a review. Obstet Gynecol 96: 849–860
Friedman SA, Schiff E, Kaa L, Sibai BM (1995) Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol 172: 1785–1792
Goldenberg RL, Cliver SP, Bronstein J et al. (1994) Bed rest in pregnancy. Obstet Gynecol 84: 131–136
Goldman-Wohl D, Yagel S (2002) Regulation of trophoblast invasion: from normal implantation to preeclampsia. Mol Cell Endocrinol 187: 233–238
Gray SE, Rodis JF, Lettieri L, Egan JFX, Vintzileos A (1994) Effect of intravenous magnesium sulfate on the biophysical profile in the healthy preterm fetus. Am J Obstet Gynecol 170: 1131–1135
Gupta AK, Rusterholz C, Huppertz B et al. (2005) A comparative study of the effect of three different syncytiotrophoblast micro-particle preparations on endothelial cells. Placenta 26: 59–66
Hall DR, Odendaal HJ, Steyn DW, Grevé D (2000) Expectant management of early onset, severe preeclampsia maternal outcome. Br J Obstet Gynecol 107: 1252–1257
Harper JMG, Murnaghan GA, Kennedy L, Hadden DR, Atkinson AB (1989) Phaeochromocytoma in pregnancy. Five cases and a review of the literature. Br J Obstet Gynaecol 96: 594–606
Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, Senat MV, Visser GHA (2001) Monitoring fetuses with intrauterine growth restriction: a longitudinal study. ultrasound Obstet Gynecol 18: 564–570
Higgins JR, de Swiet M (2001) Blood-pressure measurement and classification in pregnancy. Lancet 357: 131–135
Howie PW, Prentice CRM, Forbes CD (1975) Failure of heparin therapy to affectthe clinical course of severe preeclampsia. Br J Obstet Gynaecol 82: 711–717
Hunter SK, Martin M, Benda JA, Zlatnik FJ (1995) Liver transplant after massive spontaneous hepatic rupture in pregnancy complicated by preeclampsia. Obstet Gynecol 85: 819–822
Hüskes KP, Baumgartner A, Hardt U, Fink F (1991) Doppelseitige, mehrzeitige Spontanruptur der Leber bei HELLP-Syndrom. Chirurg 62: 221–222
Impey L (1993) Severe hypertension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 100: 959–961
Inbar O, Blank M, Faden D, Tincani A, Lorber M, Shoenfeld Y (1993) Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin. Am J Obstet Gynecol 169: 423–426
Jenkins SM, Head BB, Hauth JC (2002) Severe preeclampsia at less than 25 weeks of gestation: maternal and neonatal outcomes. Am J Obstet Gynecol 186: 790–795
Kennedy S, Hall P, Seymour A, Hague W (1994) Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol 101: 387–391
Knight M, Redman CW, Linton EA, Sargent JL (1998) Shedding of syncytro-phoblast microvilli into the maternal circulation in preeclamptic pregnancies. Br J Obstet Gynaecol 105: 632–640
Knight M, Duley L, Henderson-Smart DL, King JF (2000) Antiplatelet agents and preeclampsia (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford, Updated Software 2000
Kutteh WH (1997) Antiphospholipid antibodies and reproduction. J Reprod Immunol 35: 151–171
Lain KJ, Roberts JM (2002) Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287: 3183–3186
Levine RJ, Hauth JC, Curet LB et al. (1997) Trial of calcium to prevent preeclampsia. N Engl J Med 337: 69–76
Levine RJ, Maynard SE, Quian C et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. New Engl J Med 350: 672–683
Levine RJ, Thadhaini R, Quian C et al. (2005) Urinary placental growth factor and risk of preeclampsia. JAMA 293: 77–85
Leviton A, Kuban KC, Pagano M et al. (1993) Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics 91: 1083–1088
Lewington S, Clarke R, Qizilbash N et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data of 1 million adults in 61 perspective studies. Lancet 360: 1903–1913
Liggins GC, Howie RN (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of RDS in premature infants. Pediatrics 50: 515–525
Livingston JC, Livingston LW, Ramsey R et al. (2003) Magnesium sulfate in women with mild preeclampsia: a randomised controlled trial. Obstet Gynecol 101: 217–220
Lockwood CJ, Rand JH (1994) The immunbiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 49: 432–441
Lubarsky SL, Barton JR, Friedman SA, Nasreddine S, Ramadan MK, Sibai BM (1994) Late postpartum eclampsia revisted. Obstet Gynecol 83: 502–505
Lucas MJ, Leveno KJ, Cunningham FG (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 333: 201–205
Lydakis C, Lip GJ, Beevers M Beevers BG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12: 541–547
Magee LA, Ornstein MP, Von Dadelszen P (1999) Fortnightly review: management of hypertension in pregnancy. BMJ 318: 1332–1366
MacLean MA, Cameron AD, Cumming GP, Murphy K, Mills P, Hilan KJ (1994) Recurrence of acute fatty liver of pregnancy. Br J Obstet Gynaecol 101: 453–454
Magann EF, Bass D, Chauhan SO (1990) Accelerated recovery from severe preeclampsia: Uterine curettage versus Nifedipine. J Soc Gynecol Invest 1: 210–214
Magann EF, Martin JN, Isaacs JD, Perry KG, Martin RW, Mey-drech EF (1993) Immediate postpartum curretage: Accelerated recovery from severe preeclampsia. Obstet Gynecol 81: 502–506
Magann EF, Bass D, Chauhan SP, Sullivan DL, Nartin RW, Martin JN (1994a) Disease stabilisation in patients with the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 171: 1148–1153
Magann EF, Perry KG, Meydrech EF, Harris RL, Chauhan SP, Martin JN (1994b) Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 171: 1154–1158
Martin JN, Files JC, Blake PG, Norman PH, Martin RW, Hess WL, Morrison JC, Wiser WL (1990) Plasma exchange for preeclampsia I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol 162: 126–137
Matchaba P, Moodley J (2004) Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev: CD 002076
McMaster MT, Zhou J, Fisher SJ (2004) Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 24: 540–547
Ment LR, Oh W, Ehrenkranz RA, Philip AGS, Duncan CC, Makuch RW (1995) Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 172: 795–800
Merchant SH, Mathew P, Vanderjagt TJ etal. (2004) Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol 103: 1055–1058
Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J, Romney SL (1994) Preeclampsia and antioxidant nutritients: Decreased plasma levels of reduced ascorbic acid, α-Tocopherol, and β-carotene in women with preeclampsia. Am J Obstet Gynecol 1171: 150–157
Millar J, Campbell S, Albano J, Higgins B, Clark A (1996) Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine probe. Br J Obstet Gynaecol 103: 421–426
Moffett-King A (2002) Natural killer cells and pregancy. Nat Rev Immunol 2: 656–663
Montan S, Ingemarsson, Marzal K, Sjöberg NO (1992) Randomised controlled trial of atenolol and pindolol in human pregancy: effects on fetal hemodynamics. BMJ 304: 946–949
Moran P, Lindheimer MD, Davison JM (2004) The renal response to pre-eclampsia. Semin Nephrol 24: 588–595
Morris MC, Twickler DM, Hatab MR et al. (1997) Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe pre-eclampsia. Obstet Gynecol 89: 561–568
Mushambi MC, Halligan AW, Williamson K (1996) Recent developments in the pathophysiology and management of pre-eclampsia. Br J Anaesth 76: 133–148
National Institutes of Health (2000) Working group report on high blood pressure in pregnancy. Washington, DC
Nelson K, Grether JK (1995) Can Magnesium Sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95: 263–269
Ness RB, Roberts JM (1996) Heterogenous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications. Am J Obstet Gynecol 175: 1365–1370
North R, Ferrier C, Long D, Townend K, Kinkaid-Smith P (1994) Prevention of preeclampsia with prophylactic heparin and anti-platelet agents in women with underlying renal disease. Hypertens Pregn 13: 135–144
O’Brian E, Asmar R, Beilin L et al. (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23: 697–701
Odegard RA, Vatten LJ, Nilsen St et al. (2000) Preeclampsia and fetal growth. Obstet Gynecol 96: 950–955
Odendaal HJ, Pattison RC, Bam R, Grove D, Kotze TJW (1990) Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks gestation: a randomized controlled trial. Obstet Gynecol 76: 1070–1076
Olson S, Sacher NJ, Tabor A, Weber T, Walker JJ, Gland C (2000) Randomised clinical trials offish oil supplementation in high-risk pregnancies. Br J Obstet Gynecol 107: 382–395
Ounsted M (1988) The children of women who had hypertension during pregnancy. In: Rubin PC (ed) Hypertension in pregnancy. Elsevier, Amsterdam (Handbook of hypertension, vol 10, pp 341–362)
Papagorghiou At, Yu CKH, Binora R, Pandis G, Nicolaides KH (2001) Multi-center screening for preeclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 18: 441–449
Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS (1993) Antiphos-pholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 100: 909–913
Perlman JM, Risser RC, Gee JB (1997) Pregancy-induced hypertension and reduced intraventricular hemorrhage in preterm infants. Pediatr Neurol 17: 29–33
Pickard J, Jochen AL, Sadur CN, Hofeldt FD (1990) Cushing’s syndrome in pregnancy. Obstet Gynecol Surv 45: 87–93
Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miss cariage associated with phospholipidantibodies (or antiphospholipidantibodies). BMO 324: 253–257
Rasmussen S, Irgens LM (2003) Fetal growth and body proportion in preeclampsia. Obstet Gynecol 101: 575–583
Rath W, Loos W, Graeff H, Kuhn W (1992) Das HELLP-Syndrom. Gynäkologe 25: 430–440
Rath W, Loos W, Kuhn W (1994) Das HELLP-Syndrom. Zentralbl Gynäkol 116: 195–200
Redman CWG (1991) Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 17: 149–154
Redman CWG, Sargent IL (2000) Placental debris, oxidative stress and preeclampsia. Placenta 21: 597–602
Redman CWG, Sargent IL (2003) Preeclampsia, the placenta and the maternal systemic inflammatory response — a review. Placenta 24: 521–527
Redman CWG, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180: 499–506
Redman CWG (1995) Hypertension in pregnancy. In: De Swiet M (ed) Medical disorders in obstetric practice. Blackwell, Oxford, pp 182–225
Redman CWG, Ounsted MK (1982) Safety for the child of drug treatment for hypertension in pregnancy. Lancet 1: 1237
Report of the national high blood pressure education program working group an high blood pressure in pregnancy (2000) Am J Obstet Gynecol 183: S1–S22
Rey E, Couturier A (1994) The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 171: 410–416
Rey E, LeLorier J, Burgess E et al. (1997) Report of the Canadian hypertension society Consensus Conference. 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 157: 1245–1254
Reyes H, Sandoval L, Wainstein A, Ribalta J, Donoso S, Smik G (1994) Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut 35: 101–106
Riely CA (1987) Acute fatty liver of pregnancy. Semin Liver Dis 7: 47–54
Roberts JM (1995) Magnesium for preeclampsia and eclampsia. N Engl J Med 333: 250–251
Roberts JM, Hubel CA (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354: 788–789
Robinson M (1958) Salt in pregnancy. Lancet 1: 178–181
Rogue H, Paidas MJ, Funai EF et al. (2004) Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 91: 290–295
Rolfes D, Ishak K (1985) Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology 5: 1149–1158
Ruffati A, Dalla Barba B, Del Ross T et al. (1998) Outcome of fifty-five new-borns of antiphospholipid antibody-postive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 16: 605–610
Schoeman MN, Batey RG (1991) Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology 100: 544–548
Sheehan HL (1940) The pathology of acute yellow atrophy and delayed chloroform poisoning. J Obstet Gynaecol Br Emp 47: 49–61
Shojaati K, Causevic M, Kadereit B et al. (2004) Evidence for compromised aldosterone synthase enzyme activity in preeclampsia. Kidney Int 66: 2322–2328
Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 335: 275–265
Sibai BM (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100: 369–377
Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102: 181–192
Sibai BM (2004a) Diagnosis, controversies and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103: 981–991
Sibai BM (2004b) Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 190: 1520–1526
Sibai BM (2005) Diagnosis, prevention and management of preeclampsia. Obstet Gynecol 105: 402–410
Sibai BM, El-Nazar A, Gonzalez-Ruiz A (1986a) Severe preeclampsia-eclampsia in in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 155: 1011–1016
Sibai BM, Abdella TN, Spinnato JA, Anderson GD (1986b) Eclampsia V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol 154: 581–586
Sibai BM, Mercer B, Sarinoglu C (1991) Severe preeclampsia in the second trimester: Recurrence risk and long term prognosis. Am J Obstet Gynecol 165: 1408–1412
Sibai BM, Barton JR, Akl S et al. (1992) A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 167: 879–884
Sibai BM, Ramadan MK, Usta I et al. (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169: 1000–1006
Sibai BM, Mercer BM, Schiff E, Friedman SA (1994) Aggressive versus expectant management of severe preeclampsia at 28–32 weeks gestation. Am J Obstet Gynecol 171: 818–822
Sibai BM, Ramadan MK, Chari RS, Friedman SA (1995) Pregnancies complicated by HELLP-Syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 172: 125–129
Smith P, Anthony J, Johanson R (2000) Nifedipine in pregnancy. BJOG 107: 299–307
Steiner M (1989) Aktuelle Bilanz der mütterlichen Mortalität. In: Hillemanns HG, Schillinger H (Hrsg) Das Restrisiko gegenwärtiger Geburtshilfe. Springer, Berlin Heidelberg New York Tokyo, S 17–23
Steinhard J, Klockenbusch W (1999) Schwangerschaftsinduzierte Hyperto-nie und Präeklampsie. Risikofaktoren und Vorhersagemöglichkeiten. Gynäkologe 10: 753–760
Subtil D, Goeusse P, Houfflein-Deborge V et al. (2003a) Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women, pt2. BJOG 110: 485–491
Subtil D, Goeusse P, Puech F et al. (2003b) Aspririn (100 mg) used for prevention of preeclampsia in nulliparous women, pt 1. BJOG 110: 475–484
Sullivan CA, Magann EF, Perry KG, Roberst ME, Blake PG, Martin JN (1994) The recurrence risk of the syndome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 171: 940–943
The Magpie Trial (2002) Do women with preeclampsia, and their babies, benefit from magnesium sulfate? A randomised placebo-controlled trial. Lancet 359: 1877–1890
Tincani A, Brauch, W, Levy et al. (2003) Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12: 524–529
Towers CV, Piron RA, Nageotte MP et al. (1993) Cocain intoxication presenting as preeclampsia and eclampsia. Obstet Gynecol 81: 545–547
Tram WR, Shoup ME, Hale DE et al. (1996) Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets, and long chain 3-hydroxyacy-coenzyme A dehydrogenase deficiency. Am J Gastro-enterol 91: 2293–2300
Tuffnell DJ, Lilford RJ, Buchanan PC (1992) Randomised controlled trial of daycare for hypertension in pregnancy. Lancet 339: 224–227
Usta IM, Barton JR, Amon EA, Gonzalez A, Sibai BM (1994) Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol 171: 1342–1347
Uzan S, Beaufils M, Breart G, Bazic B, Capitant C, Paris J (1991) Prevention of fetal growth retardation with low dose aspirin: findings of the EPRE-DAL trial. Lancet 337: 1427–1431
Van Wijk MJ, Nieuwland R, Boer K et al. (2002) Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol 187: 450–456
Vetter K, Kilavuz Ö (1999) Dopplersonografie und Präeklampsie. Gynäkologe 10: 761–767
Villar MA, Sibai BM (1998) Clean significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during third trimester. Am J Obstet Gynecol 160: 419–423
Villar J, Abalos B, Nardin JM et al. (2004) Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol 24: 607–615
Visser W, Wallenburg HCS (1995) Temporising management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 102: 111–117
Visser W, Wallenburg ACS (1995) Maternal and perinatal outcome of temporizing menagement in 254 consecutive patients with severe preeclampsia remote from term. Eur J Obser Gynecol Reprod Biol 63: 147–153
Von Dadelszen P, Magee LA (2002) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 24: 941–945
Waugh JJ, Clark TJ, Divakaran TG et al. (2004) Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol 103: 769–777
Weinstein L (1982) Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142: 159–167
Welsch H, Krone HA (1994) Mütterliche Mortalität und HELLP-Syndrom in Bayern 1982–1992. Zentralbl Gynäkol 116: 202–206
Wilson WA, Gharavi AE, Koike T et al. (1999) International Consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42: 1309–1311
Xuong XY, Wang FL, Davidge ST et al. (2000) Maternal smoking and preeclampsia. J Reprod Med 45: 727
Yang Z, Yamada, Zhao J et al. (2002) Prospecitve screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 288: 2163–2166
Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG (2004) Cerebral infarction in eclampsia. Am J Obstet Gynecol 190: 714–720
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Schneider, H., Dürig, P. (2006). Hypertensive Schwangerschaftserkrankungen. In: Schneider, H., Husslein, P., Schneider, KT.M. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33897-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-540-33897-0_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33896-3
Online ISBN: 978-3-540-33897-0
eBook Packages: Medicine (German Language)